{"prompt": "['EudraCT Number 2019-002880-82, IRAS Number 1003208', '30.', 'Crusell MKW, Hansen TH, Nielsen T, Allin KH, R\u00fchlemann MC, Damm P, et al. Gestational', 'diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy', 'and postpartum. Microbiome 2018;6:89.', '31.', 'Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during', 'pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008;88:894-9.', '32.', 'Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, et al.', 'Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.', 'Nature 2015;528:262-6.', '33.', 'Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, et al. Butyrate Improves Insulin', 'Sensitivity and Increases Energy Expenditure in Mice. Diabetes 2009;58:1509-17', '34.', 'Wikstr\u00f6m Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis', 'of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based', 'cohort study. BJOG 2013;120:717-23.', '35.', 'Martineau MG, Raker C, Dixon PH, Chambers J, Machirori M, King NM, et al. The metabolic', 'profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance,', 'dyslipidemia, and increased fetal growth. Diabetes Care 2015;38:243-8.', '36.', 'Kreymann B, Ghatei MA, Williams G, Bloom SR. Glucagon-like peptide-1 7-36: a', 'physiological incretin in man. Lancet 1987;330:1300-4.', '37.', 'Maruyama T, Miyamoto Y, Nakamura T, Tamai Y, Okada H, Sugiyama E, et al. Identification', 'of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun', '2002;298:714-9.', '38.', 'Shima KR, Ota T, Kato K-I, Takeshita Y, Misu H, Kaneko S, et al. Ursodeoxycholic acid', 'potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion', 'in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on', 'study. BMJ Open Diabetes Res Care 2018;6:e000469.', '39.', 'S\u00e1nchez-Garc\u00eda A, Sahebkar A, Simental-Mend\u00eda M, Simental-Mend\u00eda LE. Effect of', 'ursodeoxycholic acid on glycemic markers: A systematic review and meta-analysis of clinical trials.', 'Pharmacol Res 2018;135:144-9.', '40.', 'Foghsgaard S, Andreasen C, Vedtofte L, Andersen ES, Bahne E, Strandberg C, et al.', 'Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus', 'and Independently Associated With Insulin Resistance and Waist Circumference. Diabetes Care', '2017;40:109-16', '41.', 'Murphy HR, Rayman G, Duffield K, Lewis KS, Kelly S, Johal B, et al. Changes in the', 'Glycemic Profiles of Women With Type 1 and Type 2 Diabetes During Pregnancy. Diabetes Care', '2007;30:2785-91.', '42.', 'Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International', 'Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017;40:1631-40.', '43.', 'HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER,', 'Chaovarindr U, et al. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med', '2008;358:1991-2002.', '44.', 'M\u00e9ndez-S\u00e1nchez N, Gonz\u00e1lez V, Ch\u00e1vez-Tapia N, Ramos MH, Uribe M. Weight reduction', 'and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-', 'controlled trial. Ann Hepatol 2004;3:108-12', '45.', 'Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG. Ursodeoxycholic', 'acid versus placebo, and early term delivery versus expectant management, in women with', 'intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012;344:e3799.', 'GUARD protocol V1.0 11Mar20', 'Page 48 of 53']['EudraCT Number 2019-002880-82, IRAS Number 1003208', '46.', 'Webster LM, Myers JE, Nelson-Piercy C, Mills C, Watt-Coote I, Khalil A, et al. Longitudinal', 'changes in vascular function parameters in pregnant women with chronic hypertension and', 'association with adverse outcome: a cohort study. Ultrasound Obstet Gynecol 2018; doi:', '10.1002/uog.19021.', '47.', 'Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic', 'Pulse Wave Velocity Improves Cardiovascular Event Prediction. J Am Coll Cardiol 2014;63:636-', '46.', '48.', \"Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction\", 'of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review', 'and meta-analysis. Eur Heart J 2010;31:1865-71', '49.', 'Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave', 'velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of', 'vascular function? Circulation 2002;106:2085-90.', '50.', 'Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical', 'chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.', 'Science 2006;313:1137-40.', '51.', 'Gardosi J, Francis A, Williams M, Hugh O, Loi S. Customised Centile Calculator GROW', 'v8.0.1, 2018. Gestation Network www.gestation.net', '52.', 'White IR, Horton NJ, Carpenter J, Pocock SJ (2011). Strategy for intention to treat analysis', 'in randomised trials with missing outcome data. BMJ 2011;342:d40 doi: 10.1136/bmj.d40.', '53.', 'Geller NL, Pocock SJ. Interim analyses in randomized clinical trials: ramifications and', 'guidelines for practitioners. Biometrics 1987; 43:213-23.', '54.', 'Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of', 'rigorous methods. BMJ 1996; 313: 36-39.', '55.', 'Pharmacol Res. 2018 Sep; 135:144-149. doi: 10.1016/j.phrs.2018.08.008. Epub 2018 Aug 9.', 'Effect of ursodeoxycholic acid on glycemic markers: A systematic review and meta-analysis of', 'clinical trials. S\u00e1nchez-Garc\u00eda A1, Sahebkar A2, Simental-Mend\u00eda M3, Simental-Mend\u00eda LE4.', '56.', 'Chappell LC, Bell J, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling', 'J, Williamson C*, Thornton JG* Ursodeoxycholic acid versus placebo in women with intrahepatic', 'cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet May 2019. doi:', '10.1016/S0140-6736(19)31270-X.PMID: 3137839', '57.', 'Flynn et al. Dietary patterns in obese pregnant women; influence of a behavioral intervention', 'of diet and physical activity in the UPBEAT randomized controlled trial. International Journal of', 'Behavioral Nutrition and Physical Activity (2016) 13:124', '58.', 'GUARD protocol V1.0 11Mar20', 'Page 49 of 53']\n\n###\n\n", "completion": "END"}